{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:22:44Z","timestamp":1776381764740,"version":"3.51.2"},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T00:00:00Z","timestamp":1095984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Type 2N von Willebrand disease (VWD) is characterized by a markedly decreased affinity of von Willebrand factor (VWF) for factor VIII (FVIII). The FVIII binding site has been localized within the first 272 amino acid residues of mature VWF, encoded by exons 18\u201323. Two substitutions in exon 18 of VWF gene, inducing candidate mutations Y795C and C804F were identified in the heterozygous state in two French patients who also displayed the frequent R854Q mutation in exon 20. Expression studies in Cos\u20107 cells showed that these abnormalities, which implicate cysteine residues, induced secretion, multimerization and FVIII binding defects of corresponding recombinant VWF. Results from transfection experiments with R854Q, performed to reproduce the hybrid VWF present in patient plasma, were in agreement with those obtained for patient's plasma VWF. These findings confirm the importance of the VWF D\u2019 domain in FVIII binding. In addition, this work shows that exon 18 should preferentially be sequenced in type 2N VWD patients when the frequent R854Q mutation in exon 20 has been excluded or detected in the heterozygous state.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05187.x","type":"journal-article","created":{"date-parts":[[2004,12,21]],"date-time":"2004-12-21T02:58:55Z","timestamp":1103597935000},"page":"184-189","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene"],"prefix":"10.1111","volume":"127","author":[{"given":"L.","family":"Hilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jorieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fontenay\u2010Roupie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Guicheteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fressinaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mazurier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the INSERM Network on Molecular Abnormalities in von Willebrand Disease","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.2000"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00359a012"},{"key":"e_1_2_14_4_1","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/S0021-9258(18)47430-3","article-title":"A major factor VIII binding domain resides within the amino\u2010terminal 272 amino acid residues of von Willebrand factor","volume":"262","author":"Foster P.A.","year":"1987","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_14_5_1","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.V77.9.1937.1937","article-title":"The \u2018\u2018Normandy\u2019\u2019 variant of von Willebrand disease: characterisation of a point mutation in the von Willebrand factor gene","volume":"77","author":"Gaucher C.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_14_6_1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood.V83.6.1542.1542","article-title":"Leu697\u2192Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease","volume":"83","author":"Hilbert L.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.3.1010.1010"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04163.x"},{"key":"e_1_2_14_9_1","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood.V92.12.4663","article-title":"A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind FVIII and affects its multimerization","volume":"92","author":"Jorieux S.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_14_10_1","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood.V95.10.3139","article-title":"Conformational changes in the D\u2019 domain of von Willebrand factor induced by Cys 25 and Cys 95 mutations lead to factor VIII binding defect and multimeric impairment","volume":"95","author":"Jorieux S.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_14_11_1","first-page":"18","article-title":"Dosage de l'antig\u00e8ne li\u00e9 au facteur FVIII par la technique ELISA. Int\u00e9r\u00eat dans l\u2019\u00e9tude de la maladie de Willebrand","volume":"25","author":"Mazurier C.","year":"1977","journal-title":"Pathology and Biology"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646168"},{"key":"e_1_2_14_13_1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler J.E.","year":"1994","journal-title":"Thrombosis and Haemostasis"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05187.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05187.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05187.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T22:21:58Z","timestamp":1697408518000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05187.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05187.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05187.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"2004-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}